Capital Performance Advisors LLP Penumbra Inc Transaction History
Capital Performance Advisors LLP
- $325 Million
- Q3 2024
A detailed history of Capital Performance Advisors LLP transactions in Penumbra Inc stock. As of the latest transaction made, Capital Performance Advisors LLP holds 117 shares of PEN stock, worth $28,562. This represents 0.01% of its overall portfolio holdings.
Number of Shares
117Holding current value
$28,562% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding PEN
# of Institutions
374Shares Held
29.2MCall Options Held
305KPut Options Held
192K-
Black Rock Inc. New York, NY4.26MShares$1.04 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.68MShares$897 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD1.99MShares$485 Million0.04% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT1.55MShares$378 Million1.9% of portfolio
-
State Street Corp Boston, MA1.24MShares$302 Million0.01% of portfolio
About Penumbra Inc
- Ticker PEN
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 37,888,400
- Market Cap $9.25B
- Description
- Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...